NEW YORK — The US Food and Drug Administration on Tuesday issued separate Emergency Use Authorizations (EUAs) for PCR-based SARS-CoV-2 tests developed by the University of Alabama at Birmingham (UAB) and clinical laboratory HealthQuest Esoterics.
NEW YORK — The US Food and Drug Administration on Tuesday issued separate Emergency Use Authorizations (EUAs) for PCR-based SARS-CoV-2 tests developed by the University of Alabama at Birmingham (UAB) and clinical laboratory HealthQuest Esoterics.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.
Privacy Policy. Terms & Conditions. . Copyright © 2021 GenomeWeb, a business unit of Crain Communications. All Rights Reserved.